QIAGEN acquire OmicSoft Corporation

News   Jan 09, 2017 | Qiagen

 
QIAGEN acquire OmicSoft Corporation
 
 
 
 

RELATED ARTICLES

Biological Fingerprint of Tuberculosis Meningitis Discovered in Children

News

Children with tuberculosis meningitis have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments.

READ MORE

BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-Oncology

News

QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.

READ MORE

Boehringer Selects NOVA-EM for Their Global Environmental Monitoring Program

News

Boehringer Ingelheim plans to implement and validate the NOVA-EM (Environmental Monitoring) solution at multiple sites worldwide.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Informatics & Automation Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE